Audits, QMS, and regulatory change — written by people who run audits, not a content team.
Insights register·8 entries·Updated 2026QA teams are quietly using ChatGPT to draft SOPs. Inspectors are noticing — the 4 compliance problems and a defensible framework for AI-assisted document development.
Read →QMSR killed the audit-records exemption. FDA can now inspect your internal audit reports, management review minutes, and supplier audit records. What that means for your next inspection.
Read →CAPA topped FDA warning-letter violations in FY2025. The 3 red flags of ineffective CAPA, and a root-cause framework that actually prevents recurrence.
Read →AI can accelerate gap assessments, but generic tools introduce hallucination and audit-trail risks. A 5-point framework for using AI responsibly in compliance work.
Read →Document-control violations account for 60%+ of FDA 483s. The 5 critical mistakes that fail audits — and how to fix them before your next inspection.
Read →FDA warning letters for supplier-control failures cost $2.3M on average to fix. Check whether your quality agreements meet 21 CFR 820.50 and ISO 13485.
Read →CDER warning letters surged 50% in FY2025. The supplier compliance findings that keep appearing in 483s — and what you can actually do about them.
Read →The February 2, 2026 QMSR deadline has passed. What FDA inspectors are looking for, and how to verify your transition is complete.
Read →Regulatory updates and field notes from real audits. No spam, unsubscribe anytime.